Skip to main content

Rathbones Group PLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1351991 Liverpool, X0

Position in XENE

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,376,177
+$315,467 QoQ
Shares Held
23,666
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rathbones Group PLC holds $8,220,550 across 18 Biotechnology names. XENE ranks #2 (16.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 XENE
Xenon Pharmaceuticals Inc.
This page
23,666 $1,376,177

All Filings in XENE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,376,177 23,666
2025-12-31 $1,060,710 23,666
2025-09-30 $950,189 23,666
2025-06-30 $740,745 23,666
2025-03-31 $793,994 23,666
2024-12-31 $927,707 23,666
2024-09-30 $931,730 23,666
2024-06-30 $922,737 23,666
2024-03-31 $1,018,821 23,666
2023-12-31 $1,090,055 23,666
2023-09-30 $808,430 23,666